AIP gene mutation analysis
Chlamydia trachomatis NA, Liquid Cytology
CD4 T-Cell Recent Thymic Emigrants (RTE)
FoundationFocus CDxBRCA
Spectrum™ Pre-implantation Genetic Testing
Tissue Transglutaminase (tTG) Antibody, IgG
Strata Select™, EpiSwitch® CiRT for Immunotherapy Management
Clobazam, Urine
Adenosine Deaminase, CSF
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
Medical Test
Methodology
Access to
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
is restricted.
Sign up now
Loading...